Table 3 Comparison of diagnostic performance of CT attenuation-based parameters for assessing hepatic steatosis between patients with and without severe fibrosis.

From: Three-dimensional organ segmentation-derived CT attenuation parameters for assessing hepatic steatosis in chronic hepatitis B patients

Hepatic steatosis grades

CT parameters

AUROC (95% CI)

P-value*

Patients with severe fibrosis (n = 70)

Patients without severe fibrosis (n = 173)

Mild

L_pre

0.645 (0.521–0.756)

0.698 (0.623–0.765)

0.56

L-S_pre

0.568 (0.444–0.686)

0.634 (0.557–0.706)

0.48

L_post

0.623 (0.499–0.736)

0.694 (0.620–0.762)

0.40

L-S_post

0.516 (0.394–0.638)

0.642 (0.566–0.713)

0.15

Moderate

L_pre

0.676 (0.554–0.783)

0.804 (0.737–0.861)

0.22

L-S_pre

0.616 (0.492–0.730)

0.707 (0.633–0.773)

0.43

L_post

0.621 (0.497–0.734)

0.744 (0.673–0.808)

0.19

L-S_post

0.564 (0.440–0.682)

0.706 (0.633–0.773)

0.15

Severe

L_pre

0.659 (0.536–0.769)

0.843 (0.781–0.894)

0.13

L-S_pre

0.687 (0.565–0.793)

0.742 (0.670–0.806)

0.66

L_post

0.706 (0.585–0.809)

0.755 (0.684–0.817)

0.58

L-S_post

0.525 (0.402–0.646)

0.765 (0.695–0.826)

0.037

  1. Note. – AUROC, area under the receiver operating characteristic curve; CI, confidence interval; L_pre and L_post refer to the mean liver HU on pre- and post-contrast CT images, respectively; L-S_pre and L-S_post refer to the difference in mean HU between the liver and spleen on pre- and post-contrast CT images, respectively. *Calculated using z-statistics.